Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-01-02 @ 12:25 PM
Study NCT ID:
NCT01237067
Status:
COMPLETED
Last Update Posted:
2019-12-17
First Post:
2010-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
110022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None